Cargando…
Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era
SIMPLE SUMMARY: The potential interference at the immune response level between COVID-19 and cancer therapy raises key clinical questions and points out scientific issues that need to be promptly addressed. Among the therapeutic strategies available in oncological clinics, major concerns are raised...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071446/ https://www.ncbi.nlm.nih.gov/pubmed/33921021 http://dx.doi.org/10.3390/cancers13081906 |